Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Implantica announces filing of comprehensive eHealth patent applications for its platform technology

Implantica AG (publ), an emerging and fast growing med-tech company that is pioneering innovative solutions to treat chronic health conditions with smart implants, today announces that it has concluded an extensive eHealth patent filing that exceeded 25’000 pages, the culmination of a full year’s work of Implantica’s team and patent attorneys. The filing encompasses 59 new patent applications focused on Implantica’s eHealth platform and a broad range of applications.This comprehensive filing represents a considerable strengthening and term-extension of Implantica’s patent protection. The

Phase 1 Progress

21 February 2022 IOG plc Phase 1 Progress IOG plc ("IOG", or "the Company"), (AIM: IOG.L), the Net Zero UK gas and infrastructure operator focused on high return projects, provides the following operational update. Andrew Hockey, CEO of IOG, commented: "The IOG leadership team attended Bacton terminal late last week to go through a Pre-Start Up Safety Review ahead of final Saturn Banks commissioning. Terminal operator Perenco, executing works on IOG's behalf, advised us that the current stormy weather has hampered the final construction and leak testing programme with a knock-

Observe Medical ASA - Disclosure of large shareholding

Mandatory disclosure pursuant to section 4-2 of the Norwegian Securities Trading Act by TopRidge Pharma (Ireland) Limited ("TopRidge Pharma"). Reference is made to the previous stock exchange announcements from Observe Medical ASA (the "Company") announcing a fully underwritten rights issue of 25,714,286 new shares in the Company, raising gross proceeds of approximately NOK 180 million (the "Rights Issue"). In the Rights Issue, each existing shareholder of the Company as of 4 February 2022 (and being registered as such in Euronext Securities Oslo, the Norwegian Central Securities

Akobo Minerals enters into partnership with Oromia Bank

Akobo Minerals (Euronext Oslo – “AKOBO”), the Scandinavian-based Ethiopian gold exploration and mining company, today announced that it has signed a memorandum of understanding (MOU) with the Ethiopian commercial bank, Oromia Bank.Under the terms of the MOU, Akobo Minerals and Oromia Bank, as leaders in their respective fields, will cooperate to develop domestic services related to financing new exploration and mining projects, in accordance with international standards. Together, these services can support the advancement of Ethiopia’s domestic mining industry.  Through their

Saab Unveils the Deployable 5G Network ‘DeployNet’

Saab is launching a state-of-the art, ruggedised, 5G communication system for military and crisis operations at the Umex SimTEX 2022 exhibition in the UAE. DeployNet, locally developed by Saab in the UAE, further demonstrates Saab’s commitment to creating world-class Emirati defence and security solutions, for national needs as well as for export to the global market.A key fundamental for efficient command and control in military and crisis operations is communication. DeployNet provides a scalable 5G/LTE wireless network for the most challenging environments, offering high-capacity

Assemblin awarded multidisciplinary contract in Umeå

Assemblin has been awarded a contract for the multidisciplinary installation of electrical, HVAC and sprinkler systems as part of a project in the new district Östra Station in Umeå.Construction will begin in the spring, providing the growing district with an additional residential building and an office block. The project is a collaboration with NCC and Assemblin’s contract is worth approximately SEK 86 million. The ongoing development of the Östra Station district will see the expansion of Umeå city centre, with new homes, offices and services built in a central location where

Observe Medical ASA – Last day of trading in subscription rights

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE Reference is made to Observe Medical ASA's (the "Company") stock exchange announcement published on 9 February 2022 regarding the commencement of the subscription period in the rights issue of 25,714,286 new shares in

Akobo Minerals on Finansavisen TV

Akobo Monday! Meet our CEO Jørgen Evjen in TV interview at Finansavisen - Økonominyhetene. Monday 21.02 approx 15:00 CET. Q4 results and more. Watch live or recording at https://tv.finansavisen.no, Facebook  or as podcast https://apple.co/3JAoYQA (Norwegian finance press). Also, as previously announced, we will release fourth quarter results 2021 tomorrow 21 February at 08.30 CET. The results will be presented in a webcast with CEO Jørgen Evjen and COO Matt Jackson at 10.00 CET. The presentation and subsequent Q&A session will be held

Norway Royal Salmon ASA (NRS): Requirement to notice an extraordinary general meeting of NRS ASA

Norway Royal Salmon ASA has today received a request to notice an extraordinary general meeting. With reference to the Public Limited Liability Companies Act § 5-7, the main owner of Norway Royal Salmon ASA, NTS ASA which owns 68.1% of the shares in the Company, requests that the board of Norway Royal Salmon ASA should notice as soon as possible to an extraordinary general meeting where the election of a new board is on the agenda. For more information, please contact: CFO Ola Loe, +47 911 79 411 . About NRS: The Norway Royal Salmon (NRS) group owns 36 085 tonnes MAB for

VP of Sales and General Manager for MapsPeople Inc.

MAY NOT BE PUBLISHED, DISTRIBUTED, OR SUPPLIED OR IN PARTICULAR, DIRECTLY OR INDIRECTLY, IN OR TO THE USA, AUSTRALIA, CANADA, OR JAPAN. Company Announcement No. 2 - 2022 - Inside Information Aalborg, February 18[t][h], 2022MapsPeople hires VP of Sales and General Manager for MapsPeople Inc. MapsPeople is pleased to announce that Brian Parks has joined the company to lead and further develop our strong presence in the Americas. Brian has extensive experience from the SaaS industry, where he has successfully scaled software organizations several times. Brian has been leading a

Nordea Bank Abp: Repurchase of own shares on 18.02.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares18.02.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 18.02.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XSTO 557,416 10.32 5,754,321.52XHEL 399,617 10.33 4,127,284.34CEUX 470,299 10.32 4,852,133.46AQEU 37,428 10.31

Intrum’s Nomination Committee proposes New Chair of the Board

The Nomination Committee of Intrum AB proposes that Magnus Lindquist is elected Chair of the Board of Directors of the company at the Annual General Meeting on 29 April, 2022. The current Chair Per E. Larsson has declined re-election.Magnus Lindquist has several years of international experience, both in executive and non-executive roles in public and private companies. Magnus Lindquist will bring experience from many industries in rapidly changing environments such as Services and Fintech. Magnus Lindquist is co-Managing Partner of CORDET Capital Partners and a member of the Board of

Notice convening the Annual General Meeting of Dampskibsselskabet NORDEN A/S

ANNOUNCEMENT NO. 45 – 18 FEBRUARY 2022 18 February 2022 Notice is hereby given that the annual general meeting will convene in Dampskibsselskabet NORDEN A/Sat 2.00 p.m. CET on Thursday 24 March 2022,at the Copenhagen Marriott Hotel, meeting room Vesterhavet I,Kalvebod Brygge 5, 1560 Copenhagen V The Annual General Meeting will be held as a hybrid general meeting allowing for either physical or electronic participation. After the general meeting NORDEN will host a canapé reception. AGENDA:         A.        The Board of Directors' report on the activities of the

Nel ASA – Mandatory notification of trade by primary insider

(Oslo, 18 February 2022) Jon André Løkke, CEO of Nel ASA (“Nel”) has today sold 1,000,000 shares in Nel at an average price of NOK 12.8643 per share. After the transaction, Mr. Løkke holds 1,000,000 shares in Nel. This information is subject to the disclosure requirements in articles 19 of the Regulation EU 596/2014 (the EU Market Abuse Regulation) and section 5-12 of the Norwegian Securities Trading Act.

Endomines resolves on a fully guaranteed directed share issue to noteholders to strengthen financial position enabling further development

Endomines resolves on a fully guaranteed directed share issue to noteholders to strengthen financial position enabling further development Endomines AB, Stock Exchange Release 18 February 2022 at 18:30 CET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, NEW ZEALAND, THE UNITED STATES, OR ANY OTHER COUNTRY WHERE SUCH PUBLICATION, NOTICE OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE PREPARED OR REGISTERED OR REQUIRE ANY

SRV Group Plc: Repurchase of own shares on 18 February 2022

SRV GROUP PLC     STOCK EXCHANGE RELEASE     18 FEBRUARY 2022      18:45 EET   SRV Group Plc repurchase of own shares on 18.02.2022     +------------------------+----------+|SRV Group Plc |  |+------------------------+----------+|In the Nasdaq Helsinki |  |+------------------------+----------+|Date |18.02.2022|+------------------------+----------+|Exchange transaction |BUY |+------------------------+----------+|Share trading code |SRV1V |+------------------------+----------+|Amount, shares

Conclusion of share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The following

Valmet Oyj: Acquisition of own shares 18.02.2022

Valmet Oyj: Acquisition of own shares 18.02.2022 Valmet Oyj's stock exchange release on February 18, 2022 at 06:30 p.m. EET  Date 18.02.2022Exchange transaction BuyShare class VALMTAmount 15,000Average price/share 31.7108 EURHighest price/share 32.0800 EURLowest price/share 31.4100 EURTotal price 475,662.00 EUR The shares held by Valmet Oyj on 18.02.2022: VALMT 513,423 On behalf of Valmet Oyj  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Janne Tiihonen For

Nordnet has repurchased own shares

Nordnet AB (publ) has during the period 10-15 February 2022 repurchased a total of 215 413 shares, in order to ensure part of Nordnet’s liabilities due to the company's long-term share-based incentive program.The average price for acquired shares amounts to 150.14 SEK per share, and the total amount is 32,341,091 SEK. The transactions have carried out on Nasdaq Stockholm. Nordnet did not previously hold any shares, and Nordnet’s total holding after the repurchase transactions amounts to 215,413 shares. The total number of outstanding shares in Nordnet amounts to 250,000,000. The

Atea ASA - share buyback

Oslo, 18 February On 18 February 2022, Atea ASA has purchased a total of 40,000 own shares at the Oslo Stock Exchange at an average price of NOK 131.60 per share. Following the completion of the above transactions, Atea ASA owns a total of 218,186 own shares, corresponding to 0.19% of Atea ASA's share capital. Additional information on the buyback program: Date on which the buyback program was announced: 11 February 2022 The duration of the buyback program: 14 February 2022 to 31 March 2022, or until the maximum number of shares has been repurchased. Size of the buyback

Double domestic expansion at Bromma Stockholm – two start-up airlines to resume direct service to Kristianstad and Trollhättan

The start-up regional airlines Skåneflyg and Västflyg are expanding the network of air routes in Sweden from Bromma Stockholm Airport and will launch direct service to Kristianstad and Trollhättan. Starting in late March, both routes will again be served from Bromma Stockholm. Before the pandemic, both Kristianstad and Trollhättan were included in Bromma Stockholm’s range of destinations on offer, but for the past two years the route has been unserved. The start-up airline Skåneflyg is now launching service to Kristianstad, while Västflyg will fly to Trollhättan. Late in 2020,

#22-57 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Radboud University Medical Center in Nijmegen, the Netherlands, has initiated an Investigator Initiated Trial (IIT) studying MR-guided FLA in localized prostate cancer using the CLS TRANBERG® products

Lund, Sweden, 18 February, 2022 – Radboud University Medical Center (Radboudumc) in Nijmegen in the Netherlands has obtained approval from its ethics committee for its Investigator Initiated Trial (IIT) to evaluate the safety and feasibility of magnetic resonance guided focused laser ablation (MRgFLA) as a focal therapy treatment for localized prostate cancer in low to intermediate risk patients, using the TRANBERG® Thermal Therapy System with Thermoguide™ Workstation.“I am very pleased that the Minimally Invasive Image-Guided Intervention Center (MAGIC) at Radboudumc, a leading European

Integrum initiates collaboration with Erie County Medical Center in New York

Mölndal, Sweden, February 18, 2022 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announced that Erie County Medical Center in Buffalo, New York, USA, has completed treatment of their first two patients with the OPRA[TM] Implant System, making it the first hospital in the state to perform surgeries with Integrum’s implant system. In parallel, Integrum will collaborate with Garwood Medical Devices, and researchers at the University at Buffalo, to develop the infection control system BioPrax.Integrum develops and markets OPRA­­[TM] – the only FDA approved bone-anchored

There are no items matching the current filter
There are no more items matching the current filter
Back to top